PLx Pharma Inc. announced that Natasha Giordano has been appointed as President and Chief Executive Officer, and as a member of the company's Board of Directors, effective January 1, 2016. Ms. Giordano will be replacing Ronald R. Zimmerman, who will remain on the Board of Directors and continue in a role as Founder and Senior Advisor providing support for pre-commercialization activities, regulatory affairs, and business development. Ms. Giordano joins PLx Pharma with over 25 years' experience as an accomplished and versatile senior leader successfully achieving enterprise-wide strategic and financial goals across industries with a focus on Pharmaceuticals and Healthcare Technologies.

Ms. Giordano is proficient in building commercialization plans including developing sales forces, raising capital, and is a skilled turnaround specialist known for her novel risk mitigation approaches. Prior to joining PLx Pharma, Ms. Giordano was President and CEO of Clear Point Learning.